Transdermal vs Injectable Peptides: Delivery, Evidence, Convenience & Limitations
Injections deliver more per dose. Patches are easier to use. Those are two different questions, and this guide answers both honestly.
Key takeaways
- Injection places a peptide beneath the skin barrier, so it delivers far more per dose and has established systemic delivery. No patch brand should pretend otherwise.
- Passive patches face a real skin barrier, especially for large, charged molecules like most peptides [1].
- Iontophoresis is an active method that can increase skin transport of some charged molecules, but how much reaches the bloodstream depends on the molecule and the system [2][3].
- Convenience and bioavailability are separate questions. A route that's easier to stick with doesn't deliver more because of it.
- LavION hasn't published human data showing how much reaches the bloodstream, and we don't claim equivalence to injections.
If you're choosing between injectable peptides and a patch, you'll find plenty of confident answers online. Most of them blur two separate questions: how much of a peptide each route delivers, and how easy each route is to live with.
This guide keeps those questions apart. It covers what injections do well, where patches fit, what the evidence supports for each, and what we can and can't claim about LavION.
The central difference: route
Subcutaneous, intramuscular and intravenous routes bypass the outer skin barrier. Nothing has to cross the stratum corneum, survive stomach acid or move through a layer of skin fats. For large, charged, water-loving molecules, which describes most peptides, that's a large and genuine advantage.
A transdermal patch has to get through that barrier. That single difference changes what evidence you need before comparing doses or effects between the two.
Side by side
| Factor | Injectable peptides | Transdermal patch (LavION) |
|---|---|---|
| Delivery per dose | Highest; bypasses the skin barrier | Lower; depends entirely on the delivery method. Not measured in published human studies for LavION |
| Mechanism | Needle places the peptide beneath the skin | Iontophoresis: a low current helps move charged molecules into the skin |
| Preparation | Reconstitute powder, draw, inject | Mix the dry blend with the included sterile water, add it to the patch pad, apply |
| Storage | Usually cold once mixed; limited stability | Unmixed formula stores at room temperature, up to 3 years when stored as labeled |
| Schedule | Varies; often frequent injections | One patch every 5 days, worn up to 12 hours |
| Travel | Coolers, vials, syringes, sharps | Pouches in a bag; small water vial fits the liquids bag |
| Local risks | Injection-site reactions, infection, dosing errors, sharps disposal | Skin irritation where the patch sits |
| Sourcing | Varies; much is sold outside pharmacy channels | Finished product with independently tested ingredient lots |
| Clinical oversight | Varies; often none | Good Faith Exam with a licensed provider before first purchase |
Why injections deliver more
An injection puts the peptide where the skin can't stop it. That's why, for a short, defined course where delivery matters most, injection is the stronger tool, especially under a clinician's direction with proper sourcing and sterile technique.
Injections also come with real friction: needles, mixing, cold storage, sharps disposal and the risk of contamination or dosing errors when people prepare doses at home. Those practical issues are real, but they don't make a more convenient route deliver the same amount.
What transdermal delivery can and can't do
Passive patches rely on the molecule diffusing through skin on its own. That works for small, fat-soluble drugs and poorly for most peptides [1][4].
Iontophoresis adds an electrical driving force. Research shows it can increase skin transport of some peptides and larger molecules compared with passive contact, with results depending on the molecule's charge and size, the formulation, pH and the current [2][3][5]. It has been used clinically for decades [2].
That supports iontophoresis as a credible delivery method. It doesn't, by itself, tell you how much of any peptide a particular product delivers into the bloodstream.
Convenience vs bioavailability
Convenience can matter in real life. A routine you can actually keep may be easier to fit around work, travel and family. But "easier to use" and "delivers the same amount" are different claims.
We'd rather say it plainly: convenience can make a routine easier to stick with, but it doesn't close the delivery gap. No published data shows a LavION patch delivers amounts comparable to an injection.
When an injection may be the better fit
- A clinician has prescribed a specific short course for a specific reason.
- The goal requires a known, high delivered amount.
- You need precise, adjustable dosing under supervision.
- You're in a clinical setting with proper sourcing, sterile technique and follow-up.
When a patch may be a better fit
- You want a needle-free option for a self-managed wellness routine.
- You travel often, and cold storage plus sharps is a non-starter.
- You have needle aversion, which is a real reason, not a soft one.
- You want disclosed amounts, independently tested ingredients and clinician review before you start.
Where LavION fits
LavION uses the ActivaPatch IontoGo 12.0 iontophoresis device, which applies a low electrical current to help move charged molecules across the skin during a wear period of up to 12 hours. LavION is needle-free and does not use microneedles. Ingredient amounts describe what is loaded into the formula, not measured delivery into the body.
Standard LavION use is one patch every 5 days, worn for up to 12 hours. A Good Faith Exam with a licensed provider is required before your first purchase.
If you're comparing LavION with a specific injectable protocol, Wolverine Stack vs TITAN walks through the most common one. For how the device works, see How It Works.
The bottom line
Injections deliver more, with established systemic delivery. Patches are easier: no needles, no mixing ahead of time and no cold storage. LavION hasn't been shown to deliver amounts equivalent to an injection, and we don't claim it does.
Whichever you choose, judge the product on disclosed amounts, a named delivery mechanism, testing documentation and whether a clinician is involved.
References
- 1.Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology. 2000;9(3):165-169. PubMed
- 2.Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Advanced Drug Delivery Reviews. 2004;56(5):619-658. PubMed
- 3.Hasan M, Khatun A, Kogure K. Iontophoresis of biological macromolecular drugs. Pharmaceutics. 2022. PMC
- 4.Prausnitz MR, Langer R. Transdermal drug delivery. Nature Biotechnology. 2008;26(11):1261-1268. PubMed
- 5.Ita K. Transdermal iontophoretic drug delivery: advances and challenges. Journal of Drug Targeting. 2016. PubMed
Frequently asked questions
Are peptide patches as effective as injections?
No published data shows that. Injections deliver more per dose, and LavION hasn't published human data on how much reaches the bloodstream. Treat any patch brand's equivalence claim as marketing.
Why do injections deliver more?
An injection places the peptide beneath the skin barrier. A patch has to move the peptide through the stratum corneum, which blocks most large, charged molecules.
Is iontophoresis the same as a passive patch?
No. A passive patch relies on diffusion alone. Iontophoresis uses a low electrical current to help move charged molecules into the skin.
Is a peptide patch safer than an injection?
A patch avoids needle-related risks like injection-site infection and sharps disposal. It can cause skin irritation, and the safety of each ingredient is a separate question. Talk to a clinician about your situation.
How often do you use a LavION patch?
Standard LavION use is one patch every 5 days, worn for up to 12 hours. Apply to clean, dry skin and rotate sites.
Can you combine patches with an injectable protocol?
Only under clinician direction. Using two routes for the same peptide changes total exposure in ways you can't estimate at home.
Keep reading
This article offers general wellness education and does not replace medical advice. Statements about LavION products have not been evaluated by the FDA, and these products are not intended to diagnose, treat, cure, or prevent disease. Peptide orders include a clinician review before fulfillment. If you are pregnant, nursing, managing a condition, or taking medication, speak with your clinician. See our medical disclaimer.